Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News | GenomeWeb

Asuragen and Life Technologies said this week that they have received the CE mark for Asuragen’s BCR/ABL1 Quant test and commercially launched the assay in Europe.

The test, manufactured by Asuragen and exclusively distributed by Life Technologies, is intended to aid clinicians in monitoring and treating individuals with chronic myeloid leukemia. The test runs on Life Tech’s Applied Biosystems CE-marked 7500 Fast Dx Real-Time PCR instrument.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.